Stocks Comparison
Idexx Laboratories vs QuidelOrtho: revenue, profit, margins and growth compared
Idexx Laboratories brought in $4.3B of revenue in fiscal 2025, QuidelOrtho $2.7B in fiscal 2025. Revenue changed by +10.4% at Idexx Laboratories and -1.9% at QuidelOrtho on the year before, so Idexx Laboratories grew faster. Idexx Laboratories kept 24.6% of its revenue as net profit, QuidelOrtho -41.5%. Free cash flow was $1.1B at Idexx Laboratories and -$83M at QuidelOrtho.
Side by side, latest fiscal year
| IDXX | QDEL | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (December 28, 2025) |
| Revenue | $4.3B | $2.7B |
| Revenue growth | +10.4% | -1.9% |
| Net income | $1.1B | -$1.1B |
| Net margin | 24.6% | -41.5% |
| Free cash flow | $1.1B | -$83M |
| Free cash flow margin | 24.6% | -3.0% |
| Earnings per share (diluted) | $13.08 | -$16.69 |
| Cash | $180.1M | $169.8M |
| Debt | $450M | $2.7B |
| Price to earnings | 39.7 | n/a |
| Market value | $40.9B | $750.2M |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #67 of 523 · Health care | #90 of 523 · Health care |
Over the years
Questions about Idexx Laboratories and QuidelOrtho
Which is bigger by revenue, Idexx Laboratories or QuidelOrtho?
Idexx Laboratories is bigger by revenue: $4.3B in fiscal 2025, against $2.7B for QuidelOrtho in fiscal 2025.
Which keeps more of its revenue as profit, Idexx Laboratories or QuidelOrtho?
Idexx Laboratories had a net margin of 24.6% in fiscal 2025; QuidelOrtho had -41.5% in fiscal 2025.
Which grew revenue faster, Idexx Laboratories or QuidelOrtho?
In their latest fiscal years revenue changed by +10.4% at Idexx Laboratories and -1.9% at QuidelOrtho.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.